Aelurostrongylosis / Lungworm (Aelurostrongylus abstrusus) in Cats

Quick Facts

🏥 Condition Name
Aelurostrongylosis / Lungworm (Aelurostrongylus abstrusus)
📋 Also Known As
Aelurostrongylosis / Lungworm (Aelurostrongylus abstrusus)
📂 Category
Internal Parasites
📁 Subcategory
N/A
🐱 Affects
Lungs and respiratory tract
🏷️ Type
Parasitic
⚠️ Severity
Moderate to Severe
💊 Treatable
Yes with medication
🔄 Contagious
Not directly
🧬 Hereditary
No
🐱 Common In
Outdoor cats that hunt, young to middle-aged cats

Aelurostrongylosis / Lungworm (Aelurostrongylus abstrusus) Overview

Aelurostrongylosis is a parasitic respiratory disease in cats caused by the lungworm Aelurostrongylus abstrusus, a nematode parasite that resides in the lung tissue and airways of infected felines. This condition represents one of the most common respiratory parasitic infections affecting domestic cats worldwide, with prevalence varying significantly by geographic region and the lifestyle of individual cats. The parasite has a complex life cycle requiring intermediate hosts, meaning cats cannot directly transmit infection to other cats but instead acquire lungworm by consuming infected prey animals or snails that harbor the parasite larvae.

Cats become infected with Aelurostrongylus abstrusus by ingesting intermediate hosts, primarily snails and slugs, or paratenic (transport) hosts such as small rodents, birds, frogs, and lizards that have themselves consumed infected gastropods. Once ingested, larvae migrate from the gastrointestinal tract through the bloodstream to the lungs, where they develop into adult worms residing in the bronchioles and alveolar tissue. Adult female worms produce eggs that hatch into first-stage larvae, which are coughed up, swallowed, and passed in feces to continue the life cycle in the environment through intermediate hosts.

The impact of aelurostrongylosis on feline health ranges from subclinical infection causing no apparent illness to severe, potentially life-threatening respiratory disease. Light infections may produce minimal or no symptoms, particularly in otherwise healthy adult cats. However, heavier worm burdens or infection in young, elderly, or immunocompromised cats can cause significant respiratory compromise characterized by chronic coughing, breathing difficulties, exercise intolerance, and general decline. The inflammatory response to worm presence and eggs in lung tissue contributes substantially to clinical disease, and secondary bacterial infections can complicate severe cases.

Aelurostrongylosis is treatable with appropriate antiparasitic medications, and most cats recover fully with proper veterinary care. Early detection improves outcomes by allowing treatment before significant lung damage occurs. Veterinary evaluation is essential for accurate diagnosis, as symptoms overlap with many other respiratory conditions, and for selecting effective treatment protocols. Prevention focuses on limiting access to intermediate and paratenic hosts, making management of hunting behavior relevant to reducing infection risk in cats living in endemic areas.

Causes of Aelurostrongylosis / Lungworm (Aelurostrongylus abstrusus)

Aelurostrongylosis is caused exclusively by infection with the parasitic nematode Aelurostrongylus abstrusus. This slender worm, measuring approximately 5 to 10 millimeters in length as an adult, belongs to the Metastrongyloidea superfamily of parasitic roundworms. The parasite has global distribution, though prevalence varies substantially by region, with higher rates generally observed in areas with temperate climates, abundant gastropod populations, and cats with outdoor hunting access. Cats serve as the definitive host where adult worms live and reproduce, while snails and slugs function as obligate intermediate hosts essential to the parasite's life cycle.

The infection cycle begins when cats ingest intermediate hosts or paratenic hosts containing infective third-stage larvae. Direct transmission between cats is not possible, as larvae passed in feces are not immediately infective and must develop within gastropod intermediate hosts. Following ingestion, larvae penetrate the intestinal wall and migrate via lymphatic vessels and blood circulation to the lungs. This migration takes approximately one to two weeks. Once in the lungs, larvae develop into sexually mature adults over about six weeks, mate, and females begin producing eggs. The complete prepatent period from infection to larvae appearing in feces is approximately six to eight weeks.

No genetic or hereditary factors predispose cats to aelurostrongylosis. Susceptibility is determined entirely by exposure to infected intermediate or paratenic hosts. Any cat that hunts or has access to snails, slugs, rodents, birds, frogs, lizards, or other potential hosts faces infection risk regardless of breed or genetic background. However, individual immune response affects disease severity, with robust immune systems often containing infections at subclinical levels while compromised immunity permits more severe disease manifestation. Kittens and young cats may develop more serious illness due to less developed immunity.

Environmental and lifestyle factors critically influence aelurostrongylosis risk. Outdoor cats with hunting behaviors face dramatically higher exposure compared to indoor-only cats. Geographic location matters, with some regions supporting high lungworm prevalence while others have minimal parasite presence. Environments with abundant gastropod populations, such as gardens, moist areas, and temperate climates with regular rainfall, support higher intermediate host density and thus increased transmission risk. Seasonal variation in gastropod activity may influence infection patterns, though year-round transmission occurs in many areas.

Risk factors for aelurostrongylosis include any behavior increasing contact with intermediate or paratenic hosts. Active hunters are at highest risk, as prey animals commonly carry infective larvae. Young cats may be more likely to play with and ingest snails or slugs. Cats in rural or suburban environments with gardens typically face higher exposure than urban cats without green spaces. Multicat households may have higher collective risk if some members hunt and bring prey home. Cats with concurrent illnesses causing immunosuppression may develop more severe clinical disease if infected, though they are not more susceptible to initial infection itself.

Symptoms & Warning Signs

Early warning signs of aelurostrongylosis can be extremely subtle or entirely absent, particularly in light infections or cats with strong immune responses. Some infected cats remain asymptomatic carriers showing no clinical signs despite harboring adult worms. When early symptoms do occur, they typically include occasional coughing that owners might attribute to hairballs or minor irritation. Cats may show slight exercise intolerance, becoming winded more quickly during play. Subtle changes in breathing patterns might be noticed by attentive owners. These early signs often develop gradually over weeks, making it easy to miss the onset of infection.

The most common symptoms of established aelurostrongylosis involve respiratory compromise of varying severity. Chronic coughing represents the hallmark clinical sign, ranging from occasional soft coughs to frequent, harsh coughing episodes. The cough may be dry or productive and often occurs in spasms. Increased respiratory rate and effort become apparent, with affected cats sometimes showing open-mouth breathing or exaggerated abdominal movement during respiration. Wheezing or abnormal lung sounds may be audible. Some cats develop nasal discharge. Exercise intolerance progresses, with cats avoiding activity and becoming lethargic.

Behavioral changes accompanying aelurostrongylosis reflect both respiratory distress and general systemic effects. Affected cats often become less active, preferring to rest rather than engage in normal play or exploration. Appetite may decrease, leading to weight loss over time. Some cats become withdrawn or seek isolation. Grooming may decline as cats feel unwell. Changes in sleeping patterns, including choosing positions that ease breathing such as sternal recumbency with extended neck, might be observed. Cats may show reluctance to engage in climbing or jumping that increases respiratory demand.

Physical signs of aelurostrongylosis extend beyond respiratory symptoms. Weight loss occurs in many chronically infected cats due to reduced appetite and increased metabolic demands of fighting infection. Poor coat condition may develop secondary to reduced grooming and overall health decline. Pale mucous membranes might indicate secondary anemia in severe cases. Muscle wasting can accompany chronic disease. Enlargement of lymph nodes may occasionally be palpable. In severe cases, cyanosis (bluish discoloration of gums and mucous membranes) indicates critical oxygen deficit requiring emergency care.

Symptom progression in aelurostrongylosis varies based on worm burden, individual immune response, and whether treatment is instituted. Light infections may remain static at mild symptom levels or even resolve spontaneously as worms complete their lifespan. Moderate to heavy infections typically progress without treatment, with respiratory symptoms worsening over weeks to months. The inflammatory response to worm presence and eggs in lung tissue causes progressive pulmonary damage. Secondary bacterial pneumonia can develop, causing sudden deterioration. Chronic infections may lead to permanent lung changes including fibrosis that persists after parasite elimination.

Emergency symptoms requiring immediate veterinary care include signs of severe respiratory distress such as open-mouth breathing, cyanosis, extreme respiratory effort with visible rib movement and abdominal press, or respiratory rate persistently above 60 breaths per minute at rest. Collapse or extreme weakness accompanying breathing difficulty constitutes a crisis. Cats that suddenly deteriorate from stable respiratory disease may have developed secondary complications requiring urgent intervention. Complete anorexia lasting more than 24 to 48 hours warrants prompt attention. Any cat showing signs of oxygen deprivation including weakness, disorientation, or bluish mucous membranes needs immediate emergency veterinary care.

Diagnosis

Initial veterinary examination for suspected aelurostrongylosis includes comprehensive history-taking about the cat's lifestyle, hunting behavior, outdoor access, and symptom timeline. The physical examination focuses heavily on respiratory assessment, including auscultation of the lungs for abnormal sounds such as crackles, wheezes, or increased bronchovesicular sounds. Respiratory rate and effort are noted. The veterinarian assesses overall body condition, checks for lymph node enlargement, and evaluates mucous membrane color and hydration. While physical examination findings can suggest respiratory disease, they cannot specifically diagnose lungworm infection, necessitating further diagnostic testing.

Diagnostic testing for aelurostrongylosis typically begins with fecal examination using specialized techniques. The Baermann technique is the gold standard, concentrating motile larvae from fecal samples through water migration. Standard fecal flotation may miss lungworm larvae, making the Baermann method important for accurate diagnosis. However, false negatives occur because larvae are shed intermittently and the prepatent period means recently infected cats test negative. Multiple fecal samples or repeated testing increases diagnostic sensitivity. Direct fecal smear examination may occasionally detect larvae but is less sensitive than concentration methods.

Additional diagnostic procedures support aelurostrongylosis diagnosis and assess disease severity. Thoracic radiographs commonly reveal characteristic patterns of diffuse interstitial to alveolar infiltrates, described as a bronchointerstitial or nodular interstitial pattern, predominantly in the caudal lung lobes. However, radiographic changes are not pathognomonic and overlap with other respiratory conditions. Blood work may show eosinophilia reflecting parasitic infection, though this finding is inconsistent. Bronchoalveolar lavage (BAL) with cytological examination may reveal eosinophilic inflammation and occasionally larvae, providing supportive evidence. PCR testing on feces or BAL fluid offers high sensitivity and specificity where available.

Differential diagnosis for aelurostrongylosis includes numerous other respiratory conditions producing similar clinical signs. Feline asthma causes coughing and respiratory distress with overlapping radiographic patterns. Other respiratory parasites including Capillaria aerophila, Paragonimus, or Eucoleus should be considered depending on geographic region. Bacterial pneumonia, viral respiratory infections, and fungal disease enter the differential. Cardiac disease causing pulmonary edema can mimic respiratory parasitism. Neoplasia affecting the lungs, including lymphoma and carcinoma, may produce similar symptoms and radiographic changes. Thorough diagnostic workup distinguishes aelurostrongylosis from these alternatives and identifies any concurrent conditions requiring treatment.

Treatment Options

Immediate treatment for aelurostrongylosis focuses on eliminating the parasitic burden and providing respiratory support for severely affected cats. For cats in respiratory distress, stabilization with oxygen supplementation, bronchodilators, and anti-inflammatory medications may be necessary before or concurrent with antiparasitic therapy. The inflammatory reaction to dying parasites can temporarily worsen clinical signs, making supportive care important particularly in heavily infected cats. Once stable, specific antiparasitic treatment begins to eliminate adult worms and larvae from the respiratory system.

Medical management of aelurostrongylosis centers on anthelmintic medications effective against Aelurostrongylus abstrusus. Several drugs have demonstrated efficacy, with fenbendazole being commonly used at various dosing protocols, typically administered daily for extended periods of one to three weeks. Newer topical antiparasitic products containing moxidectin, emodepside, or eprinomectin have shown excellent efficacy with more convenient dosing schedules, often requiring only one or two applications. Ivermectin and milbemycin have also been used successfully in some cases. The veterinarian selects the most appropriate protocol based on infection severity, drug availability, and individual patient factors. Follow-up fecal testing after treatment confirms parasite elimination.

Surgical intervention is not applicable for aelurostrongylosis itself. The condition is managed medically through antiparasitic medications and supportive care. No surgical approaches exist for removing lungworms or treating the respiratory pathology they cause. However, if diagnostic uncertainty exists, lung biopsy might rarely be performed to obtain tissue diagnosis, though this is seldom necessary given the availability of less invasive diagnostic methods including fecal testing, imaging, and BAL.

Supportive care plays an important role in managing aelurostrongylosis, particularly in cats with significant respiratory compromise. Oxygen therapy for cats with breathing difficulty may be delivered via cage, mask, or nasal cannula depending on patient tolerance. Bronchodilators such as terbutaline or theophylline help open airways narrowed by inflammation. Corticosteroids may be judiciously used to reduce inflammatory response, though timing relative to antiparasitic treatment requires veterinary judgment. Antibiotics are indicated if secondary bacterial infection has developed. Fluid therapy supports hydration in cats that have been eating and drinking poorly. Nutritional support encourages recovery in debilitated patients.

Alternative and complementary treatments have minimal established roles in managing aelurostrongylosis. No herbal remedies or alternative therapies have demonstrated efficacy against this parasitic infection. Supportive measures focusing on overall health, stress reduction, and good nutrition may support recovery but cannot replace antiparasitic medication. Physical therapy is not applicable to this condition. Owners should focus on proven veterinary treatments and avoid delaying effective therapy in pursuit of unproven alternatives.

Treatment decisions for aelurostrongylosis consider disease severity, available medications, patient factors, and practical considerations. Mild cases in otherwise healthy cats may require only antiparasitic medication. Severely affected cats need comprehensive treatment including supportive care, potentially requiring hospitalization. Cost varies significantly based on treatment intensity required, with uncomplicated cases being relatively inexpensive to treat while severe cases requiring hospitalization and extensive care carry higher costs. Expected outcomes with appropriate treatment are generally good, with most cats recovering fully, though permanent lung damage may occur in severe or chronic cases. Early treatment before extensive pulmonary pathology develops yields the best prognosis.

Recovery & Prognosis

Recovery timeline for cats treated for aelurostrongylosis varies based on initial disease severity and extent of pulmonary damage. Cats with mild infections often show rapid improvement within one to two weeks of beginning treatment, with coughing diminishing and energy returning. Moderate infections typically resolve over two to four weeks, though complete radiographic normalization may take longer. Severe cases with extensive lung involvement may require several weeks to months for full recovery, and some cats experience permanent pulmonary changes affecting respiratory function. The pretreatment duration of illness influences recovery, with prompt treatment yielding faster resolution.

Post-treatment care following aelurostrongylosis treatment includes monitoring for symptom resolution, completing any prescribed medication courses, and follow-up testing to confirm parasite elimination. Activity should be limited during acute recovery to avoid respiratory stress. Follow-up veterinary examinations assess response to treatment, with repeat thoracic radiographs often performed to document improvement. Fecal testing using the Baermann technique several weeks after treatment completion confirms successful elimination of infection. Continued monitoring for several months ensures no recurrence or persistent problems, as some cats may require retreatment if initial therapy was incomplete.

Prognosis for cats with aelurostrongylosis is generally favorable with appropriate treatment. Mild to moderate cases typically recover completely with no lasting effects. Even many severe cases respond well to treatment, though recovery takes longer. Factors affecting individual prognosis include worm burden, duration of infection before treatment, presence of secondary complications such as bacterial pneumonia, and overall patient health status. Cats with preexisting respiratory conditions or immune compromise may have more guarded prognoses. Very young kittens may develop more severe disease and face higher risks. The prognosis becomes guarded in cases with extensive pulmonary fibrosis or irreversible lung damage.

Long-term outlook for recovered cats is generally excellent for those with uncomplicated infections. Most cats return to completely normal lives with no respiratory limitations once treatment is complete. However, reinfection is possible if exposure to intermediate and paratenic hosts continues. Cats that hunt or have outdoor access in endemic areas remain at risk and may benefit from periodic deworming or monitoring. Some cats with severe infections may retain chronic respiratory changes including increased susceptibility to other respiratory conditions or reduced exercise tolerance. Permanent lung fibrosis, while uncommon with treated infection, can cause lasting respiratory compromise requiring ongoing management.

Prevention

Primary prevention of aelurostrongylosis focuses on limiting or eliminating access to intermediate and paratenic hosts. Indoor-only housing provides complete protection by preventing exposure to snails, slugs, and prey animals that transmit infection. For cats that go outdoors, minimizing hunting behavior reduces but does not eliminate risk. Supervised outdoor time, enclosed outdoor spaces (catios), or leash walking allow some outdoor access without hunting opportunity. Removing or reducing snail and slug populations around the home through environmental management may decrease local transmission risk, though this approach is difficult to implement comprehensively.

Environmental prevention strategies target intermediate hosts and transmission opportunities. Keeping cats indoors during dawn, dusk, and nighttime when gastropods are most active reduces contact. Eliminating potential snail habitat such as moist areas, plant debris, and hiding spots near cat areas decreases local gastropod density. Bird feeders and wildlife attractants that bring prey animals near the home increase paratenic host exposure and should be positioned away from areas cats access. For cats in endemic areas, environmental management alone provides incomplete protection but contributes to overall risk reduction.

No dietary interventions prevent aelurostrongylosis. The condition results from parasite ingestion rather than nutritional factors. Maintaining overall good health through proper nutrition supports immune function and may influence whether infections remain subclinical versus causing clinical disease, but cannot prevent infection itself. Owners should be skeptical of any products claiming to prevent lungworm through dietary means. Focus should remain on exposure reduction and appropriate antiparasitic protocols.

Regular veterinary care supports prevention through monitoring and appropriate prophylactic treatment. Cats in endemic areas with outdoor access may benefit from regular deworming protocols using medications effective against lungworm. Some newer broad-spectrum antiparasitic products provide activity against Aelurostrongylus when used regularly. Veterinary guidance helps determine appropriate prophylactic regimens based on individual risk assessment. Annual or more frequent wellness examinations provide opportunities to assess respiratory health, discuss lifestyle risks, and adjust prevention strategies as needed.

Early intervention when exposure is likely or symptoms develop minimizes disease impact. Prompt veterinary consultation for any new respiratory symptoms in at-risk cats allows early diagnosis and treatment before severe lung damage occurs. Cats known to have consumed snails, slugs, or prey animals might be considered for prophylactic treatment depending on local prevalence and veterinary judgment. Monitoring cats after potential exposure for early symptom development enables rapid response. Combining exposure reduction, appropriate prophylaxis for high-risk cats, and prompt treatment when infection occurs provides comprehensive aelurostrongylosis management.

Living With & Managing Aelurostrongylosis / Lungworm (Aelurostrongylus abstrusus)

Daily management for cats at risk of aelurostrongylosis or those recovering from infection involves incorporating prevention awareness into routine care. For cats with ongoing outdoor access, monitoring for respiratory symptoms should be part of regular health observation. Consistent administration of prescribed preventive antiparasitic medications on schedule maintains protection. Cats recovering from aelurostrongylosis require activity monitoring to ensure they are not overexerting while lungs heal. Medication compliance for cats on treatment courses is essential, and establishing routines for medication administration helps ensure completion.

Home environment modifications support both prevention and recovery. For at-risk cats, reducing gastropod presence around the home through habitat modification decreases exposure risk. Cat-proofing gardens by removing snail-friendly shelters helps. For cats recovering from lungworm infection, maintaining clean, well-ventilated living spaces supports respiratory recovery. Minimizing dust, smoke, and irritants that could stress healing lungs is beneficial. Comfortable resting areas that allow easy breathing, avoiding positions that compress the chest, support recovery. Climate control maintaining moderate temperatures and humidity may improve comfort for cats with compromised respiratory function.

Maintaining quality of life for cats affected by aelurostrongylosis involves balancing restrictions with enrichment. Cats requiring indoor-only restriction for prevention purposes benefit from environmental enrichment including climbing structures, interactive toys, food puzzles, and window perches for outdoor viewing. Cats recovering from infection need activity appropriate to their respiratory capacity, avoiding overexertion while encouraging gentle movement. Mental stimulation remains important even during recovery. For cats with permanent respiratory compromise from severe infection, lifestyle adjustments accommodate reduced exercise tolerance while maintaining engagement and contentment.

Ongoing monitoring and care for cats in endemic areas includes regular health assessment at home and veterinary check-ups. Observing respiratory rate, effort, and any coughing helps detect problems early. Maintaining records of any symptoms and their timing aids veterinary consultation. Follow-up fecal testing may be recommended periodically for cats with continued exposure risk. Communication with the veterinary team about any concerns enables appropriate response. Understanding local lungworm prevalence through veterinary guidance informs risk assessment and prevention decisions.

Caregiver support for managing lungworm risk or chronic respiratory effects includes access to information and veterinary guidance. Understanding the condition, including transmission routes and effective prevention, empowers informed decision-making about outdoor access. For cats with lasting respiratory effects from severe infection, learning to recognize normal versus concerning breathing patterns reduces anxiety. The financial aspects of ongoing prevention or treatment for chronic cases should be planned for. Support from veterinary teams, online communities, and educational resources helps caregivers navigate management challenges. With appropriate knowledge and vigilance, aelurostrongylosis is a preventable and treatable condition that need not significantly impact quality of life for affected cats or their owners.

Breeds at Risk for Aelurostrongylosis / Lungworm (Aelurostrongylus abstrusus)

Aelurostrongylosis does not demonstrate breed predilection, as susceptibility is determined by environmental exposure to infected intermediate and paratenic hosts rather than genetic factors. All cat breeds face equivalent infection risk when exposed to snails, slugs, or prey animals harboring Aelurostrongylus abstrusus larvae. Neither purebred nor mixed breed cats have heightened or reduced susceptibility to this parasitic infection. The condition occurs worldwide in cats of all breeds wherever the parasite's life cycle can be completed.

Lifestyle factors rather than breed characteristics determine aelurostrongylosis risk. Breeds developed for or commonly allowed outdoor lifestyles may have higher infection rates as a population due to increased exposure opportunity rather than genetic susceptibility. For example, cats kept primarily outdoors or those with strong hunting instincts face higher risk regardless of breed. Conversely, breeds commonly kept as indoor-only pets have lower infection rates due to reduced exposure. These associations reflect management practices rather than inherent breed susceptibility. Individual immune response may influence disease severity once infected, but no breed-specific immune characteristics affecting aelurostrongylosis outcomes have been identified.

Breed-specific screening for aelurostrongylosis is not performed, as the condition is environmental rather than hereditary. No genetic tests or breeding recommendations relate to this parasitic infection. Responsible breeders may advise new owners about parasite risks in their geographic region if relevant. Veterinary guidance on appropriate prevention applies equally to all breeds based on individual lifestyle and regional factors. Working with veterinarians to implement suitable prevention strategies protects cats of all breeds from this treatable respiratory parasitic condition.

Related Conditions

Several conditions commonly co-occur with or relate to aelurostrongylosis in cats. Other respiratory parasites may coinfect cats with similar exposure histories, including Capillaria aerophila (respiratory capillariasis), Eucoleus aerophilus, or in certain regions, Paragonimus lung flukes. Intestinal parasites frequently accompany lungworm in cats that hunt and consume prey. Secondary bacterial pneumonia commonly complicates severe aelurostrongylosis, requiring concurrent antibiotic therapy. Feline asthma may coexist or develop following lung inflammation from parasitic infection. Cats with compromised immunity from concurrent conditions such as feline immunodeficiency virus or feline leukemia virus infection may experience more severe lungworm disease.

Conditions with similar symptoms to aelurostrongylosis require differentiation for accurate diagnosis and treatment. Feline asthma produces coughing, wheezing, and respiratory distress with overlapping radiographic patterns, though typically shows different distribution and response to bronchodilator therapy. Bacterial and viral pneumonias cause respiratory symptoms and infiltrates but usually present more acutely with fever. Cardiogenic pulmonary edema from heart disease may mimic respiratory parasitism and requires cardiac evaluation to distinguish. Pulmonary neoplasia including primary lung tumors or metastatic disease causes progressive respiratory decline. Fungal respiratory infections, depending on geographic region, also enter the differential diagnosis.

Potential complications of aelurostrongylosis primarily involve progressive pulmonary damage and secondary infections. Chronic inflammation from persistent infection leads to pulmonary fibrosis, causing permanent respiratory compromise even after parasite elimination. Secondary bacterial pneumonia develops when damaged airways become infected, potentially causing rapid deterioration requiring aggressive treatment. Severe respiratory compromise can lead to hypoxemia and associated organ effects. Rarely, aberrant larval migration might cause pathology in non-pulmonary locations. Prevention of complications emphasizes early diagnosis and treatment before extensive lung damage occurs, appropriate supportive care during treatment, and follow-up monitoring to ensure complete resolution and detect any lasting effects requiring ongoing management.